Adults with Prader-Willi syndrome (PWS) show prematurely aged brains, being on average 8.74 years older than their chronological age, according to a neuroimaging study. This was not associated with body mass index (BMI), use of hormonal or psychotropic medications, severity of repetitive or disruptive behaviors, or intelligence quotient (IQ). The study,…
News
G71.01 is, literally, the code for Duchenne muscular dystrophy. Q93.51 stands for Angelman syndrome, and G40.419 covers generalized and treatment-resistant epilepsies, which groups like Orphanet and the American Epilepsy Society define as including Dravet syndrome. All three designations are among some 70,000 diseases listed in the latest…
Feeding Tube Awareness Week (FTAW) — taking place Feb. 3-9 — is held worldwide to provide information about tube feeding and access to support groups and resources to patients and their families. In Australia, the national charity organization ausEE will be promoting the FTAW awareness campaign. “This week…
Wearable sensors to detect movement showed differences in motor abilities in children with Prader-Willi syndrome (PWS) and Down syndrome, compared with healthy children. Researchers say these sensors could be used to personalize patient therapy based on specific motor limitations. “Dynamic balance assessment during gait in children with Down and…
A six-week remote parent-training intervention for children with Prader-Willi syndrome (PWS) got good acceptability and satisfaction scores from parents, supporting the use of telehealth to manage the social and emotional impairments of children with this rare condition, a study reports. The study, “The PRETEND Program: Evaluating the Feasibility of…
Impairments in behavioral and working memory tasks are seen in people with Prader-Willi syndrome (PWS) compared with healthy controls, a new study shows. The study, “Investigation of the relationship between electrodermal and behavioural responses to executive tasks in Prader-Willi syndrome: An event-related experiment,” was published in the journal…
New Book Written by Mother of Child with PWS Offers Fresh Perspective on Special-needs Children
Liza Zickefoose has six children. As if that’s not challenging enough, one of them, Bridgette Nicole Johnston, has Prader-Willi syndrome (PWS). But from Zickefoose’s perspective, her daughter has a special purpose — to teach people of God’s love. That epiphany led to her writing a picture book titled “More…
Neonatal hypotonia (low muscle tone), reduced fetal movement, feeding difficulties, and cryptorchidism (undescended testes) should immediately suggest a diagnosis of Prader-Willi syndrome (PWS), according to a recent study. “Neonatal Features of the Prader-Willi Syndrome; The Case for Making the Diagnosis During the First Week of Life,” was published in…
Saniona announced it has completed the second part of its exploratory Phase 2a study testing Tesomet (tesofensine/metoprolol) as a therapy for Prader-Willi syndrome, involving nine adolescent patients treated for three months. The treatment seemed to be well-tolerated, and eight of the nine participants agreed to continue in a 24-week open…
A Phase 3 trial of Levo Therapeutics‘ treatment candidate LV-101 (intranasal carbetocin) is enrolling participants ages 7-18 with Prader-Willi syndrome. Patients are being recruited at the University of Florida and Vanderbilt University, with Levo anticipating additional study sites to open. Updates on trial sites can be found…
Recent Posts
- Study links age, genetic cause to quality of life in Prader-Willi syndrome
- Understanding the causes of anxiety in PWS helps to process the questions
- Vykat XR safely quiets the intense Prader-Willi hunger for years
- First participant dosed in Phase 2a trial of CSTI-500 for Prader-Willi syndrome
- Setmelanotide successfully targeting extreme hunger, obesity in PWS trial
- PWS study disputes growth hormone link to infant sleep apnea
- Summertime with PWS means sun, fun, and structure
- Waist size may flag higher metabolic risk in people with PWS
- Sensory processing issues act as major driver of irritability in PWS
- Heart data prompts FDA to halt trial of Prader-Willi syndrome drug ARD-101